LORI BLACKBURN: Open Payments
NPI 1780791749 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 36 payments from 15 companies in 2025. Trend: 2023 $1,416 · 2024 $876 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $136 |
| Novo Nordisk Inc | 5 | $101 |
| ABBVIE INC. | 3 | $50 |
| Viatris Specialty LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: REXULTI, Ozempic, YUPELRI, Auvelity, GVOKE HYPOPEN, Kerendia, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
